This week: Europe writes bigger cheques for edge AI, surgeons get sharper intra-op vision, and regulators quietly upgrade the “plumbing” that makes scale possible.
People on the move
Precision IO Group (Quantum Surgical + NeuWave Medical)
Kurt Azarbarzin appointed CEO as the new parent company forms around Quantum’s acquisition of J&J’s NeuWave Medical. The industrial logic is clear: pair a CE-marked ablation robot platform with a widely adopted microwave ablation portfolio, signaling “grown-up” consolidation energy in remote intervention.
Money flows
Axelera AI (Netherlands) $250M+ (€211M), Series B, led by Innovation Industries.
Edge AI semiconductors; a very loud signal that “compute at the point of care” (imaging, OR, monitoring) is becoming strategic infrastructure, not a nice-to-have. Axelera AI became the first unicorn in the EIC Scaling Club.
Oska Health (Germany) €11M, Growth financing,
AI-enabled chronic care support; the bet is that multimorbidity management scales better when human coaches get an AI “exoskeleton” for operations and personalization.
YOU(th) Health Tech $4.5M, Early-stage round led by Callisto Health.
Smartphone-based preventive screening; investors are effectively backing “preventive care as a two-minute habit,” rather than a quarterly scheduling nightmare
Clee Medical (Switzerland) — Undisclosed, Seed led by High-Tech Gründerfonds (HTGF), intraoperative imaging for stereotactic neurosurgery; funding backs real-time visibility in the brain to reduce clinical uncertainty.
On the press
European Health Data Space (EHDS) gets more “operating manual”
A TEHDAS2-flavoured roadmap signals the next phase of the EHDS is less “grand vision” and more “cross-border plumbing”: governance, secondary-use operations, and the boring bits that decide who can actually scale data reuse.
UK registration transparency upgrade
As of February 23, medical device brand and trade names have begun appearing publicly in the MHRA’s Public Access Registration Database (PARD), providing founders and investors with unprecedented real-time visibility into competitor registrations.
One thing to remember
Capital is quietly clustering around platforms that reduce friction: chronic-care “between visits,” preventive screening “without appointments,” and procedure tech that standardizes hard workflows. If your product makes adoption feel like fewer steps (not more dashboards), you are swimming with the current this week.
